Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IRZPG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AB-160
|
|||||
| Synonyms |
AB160; AB 160; nab-paclitaxel/bevacizumab complex
Click to Show/Hide
|
|||||
| Organization |
Mayo Clinic
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Melanoma [ICD11:2C30]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Vascular endothelial growth factor A (VEGFA)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.